Success Metrics

Clinical Success Rate
50.0%

Based on 4 completed trials

Completion Rate
50%(4/8)
Active Trials
0(0%)
Results Posted
50%(2 trials)
Terminated
4(44%)

Phase Distribution

Ph phase_2
2
22%
Ph phase_3
4
44%
Ph phase_1
1
11%
Ph phase_4
2
22%

Phase Distribution

1

Early Stage

2

Mid Stage

6

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
1(11.1%)
Phase 2Efficacy & side effects
2(22.2%)
Phase 3Large-scale testing
4(44.4%)
Phase 4Post-market surveillance
2(22.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

4 of 8 finished

Non-Completion Rate

50.0%

4 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Active(1)
Completed(4)
Terminated(4)

Detailed Status

Terminated4
Completed4
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
50.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (11.1%)
Phase 22 (22.2%)
Phase 34 (44.4%)
Phase 42 (22.2%)

Trials by Status

terminated444%
completed444%
not_yet_recruiting111%

Recent Activity

0 active trials
Showing 5 of 9
not_yet_recruitingphase_4

Fospropofol Disodium ED95 for Elderly Spinal Anesthesia Sedation

NCT07333508
terminatedphase_2

A Study of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Elderly Patients Undergoing Elective Colonoscopy

NCT00209599
terminatedphase_3

A Study of AQUAVAN® Injection for Sedation in Elderly Patients Undergoing Flexible Bronchoscopy

NCT00209586
terminatedphase_3

A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Minor Surgical Procedures

NCT00209560
terminatedphase_4

Lusedra (Fospropofol Disodium) for Minimal to Moderate Sedation for Regional Anesthesia Block Prior to Orthopedic Surgery

NCT01195103
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT07333508Phase 4

Fospropofol Disodium ED95 for Elderly Spinal Anesthesia Sedation

Not Yet Recruiting
NCT00209599Phase 2

A Study of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Elderly Patients Undergoing Elective Colonoscopy

Terminated
NCT00209586Phase 3

A Study of AQUAVAN® Injection for Sedation in Elderly Patients Undergoing Flexible Bronchoscopy

Terminated
NCT00209560Phase 3

A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Minor Surgical Procedures

Terminated
NCT01195103Phase 4

Lusedra (Fospropofol Disodium) for Minimal to Moderate Sedation for Regional Anesthesia Block Prior to Orthopedic Surgery

Terminated
NCT01271569Phase 1

A Study to Assess the Efficacy and Safety of Fospropofol Disodium

Completed
NCT00209534Phase 2

A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Elective Colonoscopy

Completed
NCT00209573Phase 3

A Study of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Patients Undergoing Elective Colonoscopy

Completed
NCT00209547Phase 3

Study to Assess Safety and Efficacy of AQUAVAN® Injection for Sedation During Cardiac Catheterization

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9